Belgium, October 2023 - The report “Attracting Life Science Investments in Europe” is an initiative of the BioMed Alliance, EuropaBio and Johnson & Johnson.
Considering the magnitude and importance of life sciences in Europe, from education to academia, research, manufacturing, exports and health delivery, the topic deserves a strong and coherent long term policy vision and plan. Europe spends an estimated 1,400 billion euro on healthcare annually, and its life science industry has a production turnover of 425 billion euro. There are around 9,51 million people employed in healthcare in the EU, and another 840,000 in the life science industry.
The objective of this report is to provide a set of indicators of importance for life science investments, allowing each country to identify its position on key aspects and to assess its strengths and weaknesses, making it possible for them to fill specific gaps or to work towards distinct investment profiles by adopting new policy
measures. 

Source: SEBOIO, Health Policy Consulting